APA (7th ed.) Citation

RSP, S., GS, W., EP, K., LM, C., H, E., R, S., . . . RS, O. (2022). Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development. Clinical pharmacology and therapeutics, 112(6), 1201. https://doi.org/10.1002/cpt.2683

Chicago Style (17th ed.) Citation

RSP, Singh, et al. "Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development." Clinical Pharmacology and Therapeutics 112, no. 6 (2022): 1201. https://doi.org/10.1002/cpt.2683.

MLA (9th ed.) Citation

RSP, Singh, et al. "Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development." Clinical Pharmacology and Therapeutics, vol. 112, no. 6, 2022, p. 1201, https://doi.org/10.1002/cpt.2683.